Accessibility of Community Pharmacy-Based Pharmaceutical Care Service in Korea

우리나라 지역약국 약료서비스의 접근성 현황

  • Received : 2014.10.10
  • Accepted : 2014.11.13
  • Published : 2014.12.31

Abstract

Objective: Objective of this study was to investigate community pharmacy-based pharmaceutical care accessibility in Korea. Survey on the current pharmaceutical care service provision was performed by PM2000 XE, a real-time pharmacy manager program, operated by Korea Pharmaceutical Information Center beginning November 4, 2013 until December 6, 2013 towards all community pharmacies throughout the nation which use the program. Method: The survey questionnaire consisted of four sections: pharmacy type, time-based accessibility, item-based accessibility, and spatial accessibility for non-prescription drugs. Results: Number of pharmacy responded to the survey was 331, and size of the responding pharmacy was mostly medium-scale (66.47%) with 30-99 prescription fillings a day. Proportion of pharmacy with opening hour of 12 hours or longer was only 53.77% and it was less than 25% during saturdays and holidays. Item-based accessibility was generally acceptable for prescription and non-prescription drugs, medical devices, and health supplements. However, spatial accessibility for non-prescription drugs was problematic because only one quarter of the drugs was displayed over the counter, and most of the drugs were behind the counter so that customers could not reach out. Conclusion: Based on the survey result, current situation for accessibility of pharmaceutical care service in Korea is concluded inadequate and therefore needs multidimensional efforts to improve accessibility of the service at national level such as Korea Pharmaceutical Association and Ministry of Health and Welfare.

Keywords

References

  1. Hepler CD, Strand LM. Opportunity and responsibility in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
  2. Hohmann C, Radziwill R, Klotz JM, et al. Health-related quality of life after ischemic stroke: the impact of pharmaceutical interventions on drug therapy (pharmaceutical care concept). Health Qual Life Outcomes 2010;8:59. https://doi.org/10.1186/1477-7525-8-59
  3. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000;40:157-65.
  4. World Health Organization (WHO/PHARM/94.569). The role of the pharmacist in the health care system: Report of a WHO consultative group, New Delhi, India, December 13-16 (1988) and Report of a WHO Meeting, Tokyo, Japan, August 31-September 3 (1993). (available at http://whqlibdoc.who.int/hq/1994/WHO_PHARM_94.569.pdf) accessed on October 18, 2014.
  5. World Health Organization (WHO/PHARM/DAP/96.1). Good Pharmacy Practice (GPP) in community and hospital pharmacy settings (1996) (available at http://whqlibdoc.who.int/hq/1996/WHO_PHARM_DAP_96.1.pdf). accessed on October 18, 2014.
  6. International Pharmaceutical Federation. Good Pharmacy Practice (GPP) in developing countries: Recommendations for step-wise implementation (1998) (available at http://www.fip.org/files/fip/Statements/GPP%20recommendations.pdf). accessed on October 18, 2014.
  7. World Health Organization and International Pharmaceutical Federation. Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for quality of pharmacy services. WHO Technical Report Series, No. 961, Annex 8 (2011) (available at http://www.fip.org/www/uploads/database_file.php?id=331&table_id=). accessed on October 18, 2014.
  8. Shin HT. Service Project Report on Korea Pharmaceutical Association: Enactment plan for good pharmacy practice standards. 2005.
  9. Shin HT. Service Project Report on Korea Pharmaceutical Association: Enactment plan for good pharmacy practice standards & accreditation. 2014.
  10. Lim SJ. Pharmacy professionality: accessibility is key to national health. Korea Pharmaceutical Association News, April 25 (2013). (available at http://www.kpanews.co.kr/article/show.asp?idx=154961&table=article&category=&search=&keyword=건강도우미약국&page=1&go_back=1) accessed on October 18, 2014.
  11. Lim SJ. Public late-night pharmacy service in Jeju awarded welfare model service case. Korea Pharmaceutical Association News, November 27 (2013). (available at http://www.kpanews.co.kr/article/show.asp?idx=148143 &table=article&category=&search=&keyword=공공심야약 국&page=1&go_back=1) accessed on October 18, 2014.
  12. Bae SJ. Corporate pharmacy: supplementary measure to be enacted by amendment in pharmacy affairs law. Korea Pharmaceutical Association News, January 22 (2014). (available at http://www.kpanews.co.kr/article/show.asp?idx=149925&table=article&category=&search=&keyword=복지부법인약국&page=1&go_back=1) accessed on October 18, 2014.
  13. Sega T, Sullivan DL. Assessment of pharmacists' opinions toward the behind-the-counter category of medications. J Am Pharm Assoc 2011;51:535-8. https://doi.org/10.1331/JAPhA.2011.10044
  14. Pomeranz JL, Taylor LM, Austin SB. Over-the-counter and out-of-control: legal strategies to protect youths from abusing products for weight control. Am J Public Health 2013;103:220-5. https://doi.org/10.2105/AJPH.2012.300962
  15. Hunt TL, Culbertson VL, Erramouspe J, et al. Perceptions of practicing pharmacists in Idaho about a potential behind-thecounter drug program. Ann Pharmacother 2010;44:1403-9. https://doi.org/10.1345/aph.1P056